Rachel Vaknin's most recent trade in Microbot Medical Inc was a trade of 48,125 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 48,125 | 48,125 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 4,375 | 4,375 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Rachel Vaknin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |